The Value of Neutrophil-to-Lymphocyte Ratio to Identify Bacterial Infection and Predict Short-Term Mortality in Patients with Acutely Decompensated Cirrhosis

Liver cirrhosis patients are highly susceptible to infections, affecting survival, but current parameters for detecting infection are not reliable enough in this population. We investigated the ability of white blood cell (WBC), ∆WBC, neutrophil and ∆neutrophil counts, neutrophil-to-lymphocyte (NLR) and ∆NLR ratios and C-reactive protein (CRP) and procalcitonin (PCT) levels to identify infection and predict short-term mortality in liver cirrhosis patients. We recruited 233 patients with liver cirrhosis hospitalized with acute decompensation (AD) who had an outpatient visit within 1 month (baseline laboratory data) and followed them for 90 days. Difference between laboratory values at baseline and the AD episode was defined as delta (∆) values of the parameters. Delta values did not increase the diagnostic and predictive ability of investigated parameters. The CRP level was found to be the best diagnostic marker for infection in patients with cirrhosis. However, NLR seems to be superior for short-term mortality prediction, better than the WBC count. Distinguishing inflammations of different origin is a remaining clinical challenge in acutely decompensated cirrhosis. Based on our results, NLR might be more suitable for predicting short-term mortality in patients with AD than the WBC count currently included in the CLIF-C AD score.

[1]  B. Lucke-Wold,et al.  Neutrophil to Lymphocyte Ratio and Spontaneous Bacterial Peritonitis among Cirrhotic Patients: A Systematic Review and Meta-analysis , 2022, Canadian journal of gastroenterology & hepatology.

[2]  Dwijen Das,et al.  Neutrophil to Lymphocyte Ratio (NLR) and its Correlation with Child Turcotte Pugh (CTP) Score in Prediciting Severity of Decompensated Liver Cirrhosis. , 2022, The Journal of the Association of Physicians of India.

[3]  Manaswinee Mallik,et al.  The Significant Morbidity and Mortality Indicators in Patients of Cirrhosis , 2022, Cureus.

[4]  Jiming Zhang,et al.  A neutrophil-to-lymphocyte ratio-based prognostic model to predict mortality in patients with HBV-related acute-on-chronic liver failure , 2021, BMC Gastroenterology.

[5]  B. Geller,et al.  Prognostic value of neutrophil-to-lymphocyte ratio in cirrhosis patients undergoing transjugular intrahepatic portosystemic shunt. , 2021, European journal of gastroenterology & hepatology.

[6]  Guohong Deng,et al.  Baseline Neutrophil-to-Lymphocyte Ratio Is Independently Associated With 90-Day Transplant-Free Mortality in Patients With Cirrhosis , 2021, Frontiers in Medicine.

[7]  J. Narciso-Schiavon,et al.  NEUTROPHIL-LYMPHOCYTE RATIO PREDICTS SHORT-TERM MORTALITY IN PATIENTS HOSPITALIZED FOR ACUTE DECOMPENSATION OF CIRRHOSIS. , 2021, Arquivos de gastroenterologia.

[8]  M. Papp,et al.  Abnormal ferritin levels predict development of poor outcomes in cirrhotic outpatients: a cohort study , 2021, BMC Gastroenterology.

[9]  Hongqin Xu,et al.  Neutrophil-to-Lymphocyte Ratio and Albumin: New Serum Biomarkers to Predict the Prognosis of Male Alcoholic Cirrhosis Patients , 2020, BioMed research international.

[10]  M. Mcphail,et al.  Leucocyte ratios are biomarkers of mortality in patients with acute decompensation of cirrhosis and acute‐on‐chronic liver failure , 2020, Alimentary pharmacology & therapeutics.

[11]  Jianping Wu,et al.  Evaluation of the neutrophil‐to‐lymphocyte ratio, monocyte‐to‐lymphocyte ratio, and red cell distribution width for the prediction of prognosis of patients with hepatitis B virus‐related decompensated cirrhosis , 2020, Journal of clinical laboratory analysis.

[12]  A. Sîngeap,et al.  Prognostic value of neutrophil-to-lymphocyte ratio in cirrhotic patients with acute-on-chronic liver failure. , 2020, The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology.

[13]  Bangmao Wang,et al.  Prognostic impact of neutrophil‐to‐lymphocyte ratio in cirrhosis: A propensity score matching analysis with a prespecified cut‐point , 2019, Liver international : official journal of the International Association for the Study of the Liver.

[14]  R. Jalan,et al.  Validation of CLIF-C ACLF score to define a threshold for futility of intensive care support for patients with acute-on-chronic liver failure , 2018, Critical Care.

[15]  Na Young Kim,et al.  Reference values of neutrophil-lymphocyte ratio, lymphocyte-monocyte ratio, platelet-lymphocyte ratio, and mean platelet volume in healthy adults in South Korea , 2018, Medicine.

[16]  Bangmao Wang,et al.  Prognostic nomogram incorporating neutrophil‐to‐lymphocyte ratio for early mortality in decompensated liver cirrhosis , 2018, International immunopharmacology.

[17]  J. Koskinas,et al.  Bacterial infections in patients with liver cirrhosis: clinical characteristics and the role of C-reactive protein , 2017, Annals of gastroenterology.

[18]  L. Moldawer,et al.  Microbial recognition and danger signals in sepsis and trauma. , 2017, Biochimica et biophysica acta. Molecular basis of disease.

[19]  P. Forget,et al.  Neutrophil-to-Lymphocyte Ratio Predicts Death in Acute-on-Chronic Liver Failure Patients Admitted to the Intensive Care Unit: A Retrospective Cohort Study , 2017, Shock.

[20]  K. Shi,et al.  Neutrophil-lymphocyte ratio predicts hospital-acquired bacterial infections in decompensated cirrhosis. , 2017, Clinica chimica acta; international journal of clinical chemistry.

[21]  M. Papp,et al.  Macrophage activation marker, soluble CD163, is an independent predictor of short‐term mortality in patients with cirrhosis and bacterial infection , 2016, Liver international : official journal of the International Association for the Study of the Liver.

[22]  Jian Fan,et al.  Neutrophil-to-Lymphocyte Ratio Predicts Early Mortality in Patients with HBV-Related Decompensated Cirrhosis , 2016, Gastroenterology research and practice.

[23]  Seungok Lee,et al.  The usefulness of C-reactive protein and neutrophil-to-lymphocyte ratio for predicting the outcome in hospitalized patients with liver cirrhosis , 2015, BMC Gastroenterology.

[24]  R. Moreau,et al.  The CLIF Consortium Acute Decompensation score (CLIF-C ADs) for prognosis of hospitalised cirrhotic patients without acute-on-chronic liver failure. , 2015, Journal of hepatology.

[25]  Young Youn Cho,et al.  CLIF‐SOFA scoring system accurately predicts short‐term mortality in acutely decompensated patients with alcoholic cirrhosis: a retrospective analysis , 2015, Liver international : official journal of the International Association for the Study of the Liver.

[26]  E. Taioli,et al.  Average Values and Racial Differences of Neutrophil Lymphocyte Ratio among a Nationally Representative Sample of United States Subjects , 2014, PloS one.

[27]  A. Burroughs,et al.  C-reactive protein and bacterial infection in cirrhosis , 2014, Annals of gastroenterology.

[28]  R. Moreau,et al.  Acute-on-chronic liver failure is a distinct syndrome that develops in patients with acute decompensation of cirrhosis. , 2013, Gastroenterology.

[29]  J. Hoefs,et al.  Sepsis in cirrhosis: report on the 7th meeting of the International Ascites Club , 2005, Gut.

[30]  A. França,et al.  Long-term Prognosis of Cirrhosis After Spontaneous Bacterial Peritonitis Treated With Ceftriaxone , 2001, Journal of clinical gastroenterology.

[31]  T M Therneau,et al.  A model to predict survival in patients with end‐stage liver disease , 2001, Hepatology.

[32]  P. Angeli,et al.  Bacterial infection in patients with advanced cirrhosis: a multicentre prospective study. , 2001, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

[33]  H. Eichler,et al.  Regulation of adhesion molecules during human endotoxemia. No acute effects of aspirin. , 1999, American journal of respiratory and critical care medicine.

[34]  R. Pugh,et al.  Transection of the oesophagus for bleeding oesophageal varices , 1973, The British journal of surgery.

[35]  R. Záhorec Neutrophil-to-lymphocyte ratio, past, present and future perspectives. , 2021, Bratislavske lekarske listy.

[36]  R. Wiesner,et al.  Model for end-stage liver disease (MELD) and allocation of donor livers. , 2003, Gastroenterology.

[37]  C. G. Child,et al.  Surgery and portal hypertension. , 1964, Major problems in clinical surgery.